Close



Dec 12, 2022 01:00PM
Apr 13, 2021 02:39PM
Nov 5, 2020 09:15AM
Oct 23, 2020 09:15AM
Oct 23, 2020 09:15AM
Oct 14, 2020 08:33AM
Oct 12, 2020 08:09AM Immunomedics (IMMU) Announces FDA Orphan Drug Designation of Trodelvy for Adult and Pediatric Glioblastoma
Oct 12, 2020 08:00AM
Oct 12, 2020 08:00AM
Oct 8, 2020 11:37AM
Sep 19, 2020 11:00AM
Sep 19, 2020 11:00AM
Sep 19, 2020 10:30AM
Sep 19, 2020 10:30AM Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer
Sep 18, 2020 08:01AM
Sep 18, 2020 08:00AM
Sep 18, 2020 08:00AM
Sep 14, 2020 11:55AM
Sep 14, 2020 09:30AM
Sep 14, 2020 06:59AM
Sep 13, 2020 08:03PM Gilead Sciences (GILD) to Acquire Immunomedics (IMMU) for $21 Billion
Sep 13, 2020 03:00PM
Sep 9, 2020 07:00AM
Sep 9, 2020 07:00AM
Sep 2, 2020 08:00AM
Sep 2, 2020 08:00AM
Aug 17, 2020 08:03AM
Aug 17, 2020 08:00AM Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
Aug 17, 2020 08:00AM
Aug 5, 2020 04:00PM
Aug 5, 2020 04:00PM
Jul 27, 2020 08:00AM
Jul 27, 2020 08:00AM
Jul 13, 2020 04:01PM
Jul 13, 2020 04:00PM Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers
Jul 13, 2020 04:00PM
Jul 6, 2020 07:56AM
Jul 6, 2020 07:55AM
Jul 6, 2020 07:55AM
Jul 2, 2020 04:05PM
Jul 2, 2020 04:05PM
May 28, 2020 08:00AM Immunomedics to Participate in Upcoming Healthcare Conferences
May 28, 2020 08:00AM
May 27, 2020 04:00PM
May 27, 2020 04:00PM
May 27, 2020 04:00PM
May 13, 2020 05:10PM
May 13, 2020 05:01PM
May 13, 2020 05:01PM Immunomedics to Present New Trodelvy™ Data In Non-Breast Cancer Indications at the 2020 ASCO Virtual Meeting
May 7, 2020 08:00AM

251,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All